Related Experiment Video
Updated: Nov 30, 2025
07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.9K
Eph Receptors in the Immunosuppressive Tumor Microenvironment
Peter W Janes1, Mary E Vail2, Matthias Ernst3
1Tumour Targeting Program, Olivia Newton-John Cancer Institute/La Trobe University School of Cancer Medicine, Victoria, Melbourne, Australia. peter.janes@onjcri.org.au.
Cancer Research
|November 12, 2020
Summary
Eph receptors (Eph) and ephrin ligands in the tumor microenvironment (TME) promote cancer growth and suppress immunity. Inhibiting Ephs may enhance anti-cancer immune responses and immune checkpoint therapy efficacy.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- The tumor microenvironment (TME) facilitates tumor progression and immune suppression through complex signaling.
- Eph receptors (Eph) and ephrin ligands are crucial for cell interactions in development and are reactivated in cancer.
- Eph-ephrin signaling in the TME is linked to cancer invasion, metastasis, angiogenesis, and immune evasion.
Purpose of the Study:
- To investigate the role of Eph receptors and ephrin ligands in the tumor microenvironment.
- To explore the potential of targeting Eph-ephrin signaling to overcome immune suppression in cancer.
- To assess the therapeutic implications of inhibiting Eph signaling for enhancing anti-cancer immunity.
Main Methods:
- Analysis of Eph receptor and ephrin ligand expression and function in cancer models.
- Investigating the impact of Eph inhibition on immune cell interactions within the TME.
- Evaluating the combination of Eph inhibition with immune checkpoint inhibitors.
Main Results:
- Eph receptors and ephrin ligands are actively involved in promoting tumor growth and immune suppression within the TME.
- Targeting Eph signaling can disrupt tumor-promoting activities and modulate immune cell responses.
- Inhibition of Ephs demonstrates potential to enhance the effectiveness of immune-based cancer therapies.
Conclusions:
- Eph receptors and their ligands represent critical regulators of the tumor microenvironment.
- Modulating Eph-ephrin signaling offers a promising strategy to enhance anti-cancer immunity.
- Targeting Ephs could improve the efficacy of current immunotherapies for cancer treatment.
Related Concept Videos
02:17The Tumor Microenvironment
7.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
01:27Tumor Immunotherapy
955
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
955
01:15Receptor Downregulation in MVBs
2.6K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.6K
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.5K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.5K
02:38Mitogens and the Cell Cycle
7.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K